Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
43 /100
MEDIUM RISK
Score updated Aug 28, 2026

KYNB — Kyntra Bio, Inc. Dilution Risk Tracker

Track KYNB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KYNB — Get alerts when the score changes →

As of August 28, 2026, Kyntra Bio, Inc. (KYNB) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. Kyntra Bio, Inc. has a market capitalization of $27.93M, 4.05M shares outstanding, 34 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
36
💰 Cash Runway
65
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (6mo)
🔔 Track KYNB — Get forecast alerts →

Market Data

Market Cap$27.93M
Shares Outstanding4.05M
Float3.56M
Cash$91.32M
Debt$75.00M
Short InterestN/A

Institutional Holdings

QoQ: ↓ 10.1% shares (2026Q1 vs prior)
34 institutional holders · 1.30M shares
#1 ARMISTICE CAPITAL, LLC 400.0K shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 313.2K shares
#3 ACADIAN ASSET MANAGEMENT LLC 105.6K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest97.6K
Days to Cover16.9
% of Float2.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2015-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual KYNB Dilution Snapshot

Kyntra Bio, Inc. (KYNB) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track KYNB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KYNB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for KYNB
KYNB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.